Medical Condition News

RSS

Study finds sexual dimorphism in the development of vascular insulin resistance induced by obesogenic lifestyle

A new study from the University of Missouri School of Medicine is the first evidence in humans that short-term lifestyle changes can disrupt the response to insulin of blood vessels. It's also the first study to show men and women react differently to these changes.

27 Oct 2022

Discovery points to a new understanding of Stargardt disease progression

Using a new stem-cell-based model made from skin cells, scientists found the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE).

27 Oct 2022

Pioneering gene editing technique can repair faulty T cells in patients with CTLA-4 insufficiency

A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.

27 Oct 2022

Studies find cardiovascular effects of cigarettes and e-cigarettes to be strikingly similar

Two related studies, one in humans and the other in rats, found that the cardiovascular effects of cigarettes and e-cigarettes are strikingly similar, and these harmful effects on blood vessel function are likely caused by airway irritation due to inhalation of a foreign substance, rather than a specific component of the cigarette smoke or e-cigarette vapor (aerosol), according to new research published today in the American Heart Association's peer-reviewed journal Arteriosclerosis, Thrombosis and Vascular Biology.

27 Oct 2022

Researchers develop new method to calculate the delay of signal propagations in brains of MS patients

Researchers of the Human Brain Project have developed a new methodology to calculate the delay of signal propagations in brains of patients suffering from multiple sclerosis, a chronic inflammatory disease that affects more than 2 million people worldwide.

27 Oct 2022

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

As part of an interdisciplinary project of the LOEWE Centre Frankfurt Cancer Institute (FCI), researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, and Goethe University Frankfurt have succeeded in identifying a new approach for the therapy of colorectal cancer.

27 Oct 2022

Unique gut bacteria could be responsible for triggering rheumatoid arthritis in at-risk people

Researchers at the University of Colorado School of Medicine have discovered that a unique bacteria found in the gut could be responsible for triggering rheumatoid arthritis (RA) in people already at risk for the autoimmune disease.

26 Oct 2022

Low-carb diet may be a useful approach for preventing and treating Type 2 diabetes

While low-carb diets are often recommended for those being treated for diabetes, little evidence exists on whether eating fewer carbs can impact the blood sugar of those with diabetes or prediabetes who aren't treated by medications.

26 Oct 2022

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.

26 Oct 2022

Multiple outpatient visits are key to success opioid-use disorder treatment

People with opioid-use disorder who enter treatment are at risk for relapse, overdose or death if they engage in less than two outpatient visits in their first month of care, according to a study coauthored by Rutgers researchers.

26 Oct 2022

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

A recent imaging study led by a scientist at The University of Texas at Dallas has identified early risk factors linked to children's temperament and a neural process that could foretell whether an individual might develop depression and anxiety in adolescence and early adulthood.

26 Oct 2022

New studies point to a broadly applicable treatment for neurodegenerative diseases

Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner in the death of axons, the wiring of the nervous system.

26 Oct 2022

Using magnetic bacteria to fight cancerous tumors

Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumors. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonize a tumor.

26 Oct 2022

Study tracks individuals' risk or resilience to mental health disruptions during the COVID-19 Pandemic

When the world shut down in March of 2020 because of the COVID-19 pandemic, people the world over experienced profound psychological stress to varying degrees.

26 Oct 2022

Higher exposure to particulate matter may be associated with increased dementia risk

Higher exposure to a certain type of traffic-related air pollution called particulate matter may be linked to an increased risk of dementia, according to a meta-analysis published in the October 26, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Oct 2022

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

Rates of one type of stroke called subarachnoid hemorrhage have increased in older people and men in recent years, and such strokes occur in Black people at a disproportionately higher rate compared to people of other races and ethnicities, according to a study published in the October 26, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Oct 2022

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Jessica Alber, assistant professor of biomedical and pharmaceutical sciences at the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island, is looking to change the way doctors diagnose Alzheimer's disease, a change that could raise new possibilities for treatment.

26 Oct 2022

Medical Condition News

Study finds sexual dimorphism in the development of vascular insulin resistance induced by obesogenic lifestyle

Discovery points to a new understanding of Stargardt disease progression

Pioneering gene editing technique can repair faulty T cells in patients with CTLA-4 insufficiency

Studies find cardiovascular effects of cigarettes and e-cigarettes to be strikingly similar

Researchers develop new method to calculate the delay of signal propagations in brains of MS patients

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

Unique gut bacteria could be responsible for triggering rheumatoid arthritis in at-risk people

Low-carb diet may be a useful approach for preventing and treating Type 2 diabetes

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

Multiple outpatient visits are key to success opioid-use disorder treatment

Early temperamental and neurocognitive risk factors may play a role in future anxiety, depression

New studies point to a broadly applicable treatment for neurodegenerative diseases

Using magnetic bacteria to fight cancerous tumors

Study tracks individuals' risk or resilience to mental health disruptions during the COVID-19 Pandemic

Higher exposure to particulate matter may be associated with increased dementia risk

Subarachnoid hemorrhage incidence is higher and increasing in Black patients, study says

$10.3 million NIH grant to support URI neuroscientist's research on retinal scanning to detect early-stage Alzheimer’s

Autistic women are vulnerable to mental illness, study shows

What parents need to know about prenatal tests | BGI Perspectives

$38,398 for a single shot of a very old cancer drug

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News